Community Health Systems (NYSE:CYH) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen cut shares of Community Health Systems (NYSE:CYH) from a hold rating to a sell rating in a research report sent to investors on Saturday morning.

A number of other analysts have also weighed in on the stock. Weiss Ratings raised shares of Community Health Systems from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday, July 2nd. Truist Financial boosted their price target on shares of Community Health Systems from $3.00 to $3.75 and gave the company a “hold” rating in a report on Tuesday, July 14th. UBS Group set a $3.00 price target on shares of Community Health Systems in a research report on Friday. Zacks Research lowered shares of Community Health Systems from a “strong-buy” rating to a “hold” rating in a report on Friday, April 24th. Finally, Barclays lowered their target price on Community Health Systems from $3.00 to $2.50 and set an “underweight” rating for the company in a report on Thursday. Three equities research analysts have rated the stock with a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Community Health Systems currently has a consensus rating of “Reduce” and a consensus target price of $2.81.

Community Health Systems Stock Down 3.1%

Shares of NYSE:CYH opened at $2.69 on Friday. The business’s 50 day moving average is $3.11 and its 200 day moving average is $3.13. The stock has a market cap of $379.78 million, a P/E ratio of 1.46 and a beta of 1.81. Community Health Systems has a 52-week low of $2.38 and a 52-week high of $4.43.

Community Health Systems (NYSE:CYH) last issued its earnings results on Wednesday, July 22nd. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.09). Community Health Systems had a negative return on equity of 6.66% and a net margin of 2.10%.The firm had revenue of $2.83 billion during the quarter, compared to analysts’ expectations of $2.89 billion. During the same quarter in the prior year, the company posted ($0.05) earnings per share. Community Health Systems’s quarterly revenue was down 9.8% compared to the same quarter last year. Community Health Systems has set its FY 2026 guidance at -1.250–1.100 EPS. On average, sell-side analysts anticipate that Community Health Systems will post -0.92 EPS for the current fiscal year.

Hedge Funds Weigh In On Community Health Systems

Large investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Community Health Systems by 4.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 74,987 shares of the company’s stock valued at $202,000 after purchasing an additional 3,204 shares during the last quarter. Creative Planning increased its position in Community Health Systems by 14.1% during the 2nd quarter. Creative Planning now owns 98,577 shares of the company’s stock valued at $335,000 after buying an additional 12,204 shares in the last quarter. Rhumbline Advisers raised its stake in Community Health Systems by 3.8% in the second quarter. Rhumbline Advisers now owns 206,497 shares of the company’s stock valued at $702,000 after buying an additional 7,549 shares during the last quarter. Norges Bank acquired a new stake in Community Health Systems in the second quarter worth about $1,204,000. Finally, Marshall Wace LLP purchased a new stake in shares of Community Health Systems during the second quarter worth about $321,000. 84.99% of the stock is owned by institutional investors and hedge funds.

Community Health Systems Company Profile

Community Health Systems, Inc (NYSE: CYH) is one of the largest publicly traded hospital operators in the United States. Headquartered in Franklin, Tennessee, the company owns, leases and manages general acute care hospitals and outpatient facilities, primarily in non-urban and mid-market communities. CHS is focused on delivering locally accessible healthcare services through its network of affiliated hospitals, clinics and post-acute providers.

The company’s core offerings include inpatient medical and surgical care, emergency services, critical care, diagnostic imaging and laboratory testing.